Crescent Biopharma (CBIO) Stock Chart & Stock Price History $11.84 -0.16 (-1.33%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesSEC FilingsSustainabilityTrendsBuy This Stock Crescent Biopharma Stock Price Performance The Crescent Biopharma (CBIO) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 25.49%, reflecting recent market activity. As of the latest close, Crescent Biopharma traded at $12.00 with a market cap of $234.60 million and volume of 68,160 shares. Five years ago, the stock traded at a split-adjusted price of $533.00, representing a 97.78% decrease over that period. At the time, it had a market cap of $63.18 million and a volume of 5,245 shares. Receive CBIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crescent Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.03%1 Month Performance-25.49%5 Year Performance-97.78% CBIO Stock Chart for Monday, August, 4, 2025 CBIO Chart by TradingView Crescent Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025$12.00$11.84-1.33%$12.20$11.33130,631 shs$231.47 million08/01/2025$12.42$12.00-3.38%$12.42$11.8968,160 shs$234.60 million07/31/2025$12.60$12.42-1.43%$12.80$12.3273,200 shs$242.81 million07/30/2025$12.30$12.60+2.44%$13.05$12.30122,554 shs$246.33 million07/29/2025$13.25$12.30-7.17%$13.42$12.0883,741 shs$240.47 million07/28/2025$13.29$13.25-0.30%$13.45$13.0461,545 shs$259.04 million07/25/2025$13.02$13.29+2.07%$13.50$13.0081,448 shs$259.82 million07/24/2025$13.18$13.02-1.21%$13.37$12.70120,130 shs$254.54 million07/23/2025$13.04$13.18+1.07%$13.42$12.69120,706 shs$257.67 million07/22/2025$13.20$13.04-1.21%$13.51$12.8379,364 shs$254.93 million Get the Latest News and Ratings for CBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crescent Biopharma and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025$13.34$13.20-1.05%$13.59$12.64125,978 shs$258.06 million07/18/2025$13.02$13.34+2.46%$14.01$13.03120,148 shs$260.80 million07/17/2025$13.14$13.02-0.91%$13.62$12.69124,913 shs$254.54 million07/16/2025$11.74$13.14+11.93%$13.88$11.77222,371 shs$256.89 million07/15/2025$12.80$11.74-8.28%$13.04$11.51180,668 shs$229.52 million07/14/2025$12.96$12.80-1.23%$13.85$12.70140,271 shs$250.24 million07/11/2025$13.50$12.96-4.00%$13.82$12.71342,755 shs$253.37 million07/10/2025$14.79$13.50-8.72%$14.85$13.42321,487 shs$263.93 million07/09/2025$15.09$14.79-1.99%$15.44$14.6987,680 shs$289.14 million07/08/2025$15.29$15.09-1.31%$16.02$14.75114,029 shs$295.01 million07/07/2025$15.89$15.29-3.78%$16.03$15.01103,927 shs$298.92 million07/04/2025$15.89$15.89$16.98$15.36171,070 shs$310.65 million07/03/2025$15.55$15.89+2.19%$16.98$15.36171,070 shs$310.65 million Related Companies Geron Stock Chart Zenas BioPharma Stock Chart Myriad Genetics Stock Chart Lexicon Pharmaceuticals Stock Chart Rigel Pharmaceuticals Stock Chart Emergent Biosolutions Stock Chart Verastem Stock Chart XOMA Royalty Stock Chart Vanda Pharmaceuticals Stock Chart Codexis Stock Chart Receive CBIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crescent Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CBIO) was last updated on 8/4/2025 by MarketBeat.com Staff From Our Partners[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescent Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescent Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
